首页> 外文期刊>Psychoneuroendocrinology: An International Journal >Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed.
【24h】

Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed.

机译:糖皮质激素受体转录本在主要抑郁症中的差异表达不是表观遗传学编程的。

获取原文
获取原文并翻译 | 示例
           

摘要

Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is one of the most consistent findings in major depressive disorder (MDD). Impaired HPA feedback may be due to the lower glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) levels in the forebrain. GR levels are transcriptionally controlled by multiple untranslated alternative first exons, each with its own promoter providing a mechanism for tissue-specific fine-tuning of GR levels. Recently epigenetic methylation of these GR promoters was shown to modulate hippocampal GR levels. Here we investigate in post-mortem brain tissues whether in MDD HPA axis hyperactivity may be due to epigenetic modulation of GR transcript variants. Levels of GRalpha, GRbeta and GR-P transcripts were homogeneous throughout the limbic system, with GRalpha being the most abundant (83%), followed by GR-P (5-6%) while GRbeta was barely detectable (0.02%). Among the alternative first exons, 1B and 1C were the most active, while 1E and 1J showed the lowest expression and transcript 1F expressed intermediate levels of about 1%. In MDD, total GR levels were unaltered, although GRalpha was decreased in the amygdala and cingulate gyrus (p<0.05); transcripts containing exons 1B, 1C and 1F were lower, and 1D and1J were increased in some regions. NGFI-A, a transcription factor of exon 1F was down-regulated in the hippocampus of MDD patients; concomitantly exon 1F expression was reduced. Bisulphite sequencing of the alternative promoters showed low methylation levels in both MDD and control brains. Promoter 1F was uniformly unmethylated, suggesting that reduced 1F transcript levels are not linked to promoter methylation but to the observed dearth of NGFI-A. Previous studies showed high methylation levels in the 1F promoter, associated with childhood abuse. Provided our donors were not abused, our results suggest that the pathomechanism of MDD is similar but nevertheless distinct from that of abuse victims, explaining the clinical similarity of both conditions and that susceptibility to depression may be either predisposed by early trauma or developed independent of such a condition. However, this should be further confirmed in dedicated studies in larger cohorts.
机译:下丘脑-垂体-肾上腺(HPA)轴亢进是主要抑郁症(MDD)中最一致的发现之一。 HPA反馈受损可能是由于前脑中较低的糖皮质激素受体(GR)或盐皮质激素受体(MR)水平。 GR水平由多个未翻译的替代性第一个外显子转录控制,每个外显子都有自己的启动子,为GR水平的组织特异性微调提供了一种机制。最近显示,这些GR启动子的表观遗传甲基化可调节海马GR水平。在这里,我们调查死后脑组织中MDD HPA轴是否过度活跃可能是由于GR转录本变体的表观遗传调控。在整个边缘系统中,GRalpha,GRbeta和GR-P转录物的水平均一,其中GRalpha最丰富(83%),其次是GR-P(5-6%),而GRbeta几乎检测不到(0.02%)。在替代的第一个外显子中,1B和1C活性最高,而1E和1J的表达最低,转录本1F的中间水平约为1%。在MDD中,总GR水平未改变,尽管杏仁核和扣带回中的GRalpha降低了(p <0.05)。在某些区域,含有外显子1B,1C和1F的转录本较低,而1D和1J则较高。 MDD患者海马中外显子1F的转录因子NGFI-A下调;同时,外显子1F表达降低。替代启动子的亚硫酸氢盐测序在MDD和对照大脑中均显示出较低的甲基化水平。启动子1F始终未甲基化,这表明降低的1F转录水平与启动子甲基化无关,但与观察到的NGFI-A缺乏有关。先前的研究表明1F启动子中的甲基化水平较高,与儿童期虐待有关。如果我们的捐赠者没有被滥用,我们的结果表明,MDD的发病机制是相似的,但与受虐受害者的机制不同,这说明了两种情况的临床相似性,并且抑郁的易感性可能是早期创伤的易感性或独立于此类疾病而发展的一个条件。但是,这应在较大人群的专门研究中进一步证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号